| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
5,614 |
4,372 |
$177K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,032 |
2,003 |
$35K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
414 |
381 |
$14K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
240 |
202 |
$10K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
813 |
363 |
$9K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
96 |
79 |
$2K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
840 |
707 |
$1K |
| G0008 |
Administration of influenza virus vaccine |
139 |
127 |
$1K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
160 |
150 |
$968.17 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
23 |
23 |
$748.74 |
| Q2037 |
Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin) |
71 |
69 |
$729.92 |
| 36415 |
Collection of venous blood by venipuncture |
620 |
551 |
$527.29 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
346 |
265 |
$357.32 |
| 90686 |
|
24 |
19 |
$230.60 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,441 |
1,183 |
$182.12 |